Literature DB >> 18276843

Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients' T cells by the viral Tax oncoprotein.

Klemens Pichler1, Tarek Kattan, Juliane Gentzsch, Andrea K Kress, Graham P Taylor, Charles R M Bangham, Ralph Grassmann.   

Abstract

Human T-cell leukemia virus type 1 (HTLV-1), the cause of adult T-cell leukemia, stimulates the growth of infected T cells in cultures and in nonleukemic patients. In the latter, HTLV-1 is found in long-term persisting T-cell clones. The persistence of normal T cells is controlled by the growth-stimulating and antiapoptotic functions of costimulatory receptors, while the growth-stimulating HTLV-1 functions are mediated by the viral oncoprotein Tax. Here we analyzed the impact of Tax on costimulatory receptors in T cells with repressible Tax and found that among these receptors 4-1BB (TNFRSF9/CD137/ILA) was induced most strongly. Up-regulated 4-1BB expression was a consistent feature of all HTLV-1-infected cell lines, whether patient-derived or in vitro transformed. Tax was sufficient to induce the expression of the endogenous 4-1BB gene in uninfected T cells, and it strongly activated (45-fold) the 4-1BB promoter via a single NF-kappaB site. The ligand of 4-1BB was also found on transformed T-cell lines, opening up the possibility of autostimulation. Moreover, 4-1BB expression in patients' lymphocytes ex vivo correlated with Tax expression, strongly suggesting Tax-mediated 4-1BB activation in vivo. Thus, 4-1BB up-regulation by Tax could contribute to growth, survival, and clonal expansion of the infected cells during persistence and disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18276843     DOI: 10.1182/blood-2007-10-115220

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Elevated cyclic AMP levels in T lymphocytes transformed by human T-cell lymphotropic virus type 1.

Authors:  Andrea K Kress; Grit Schneider; Klemens Pichler; Martina Kalmer; Bernhard Fleckenstein; Ralph Grassmann
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

2.  APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1.

Authors:  Marcel Ooms; Aikaterini Krikoni; Andrea K Kress; Viviana Simon; Carsten Münk
Journal:  J Virol       Date:  2012-03-28       Impact factor: 5.103

Review 3.  HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches.

Authors:  John M Taylor; Christophe Nicot
Journal:  Apoptosis       Date:  2008-06       Impact factor: 4.677

4.  Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors:  Mineki Saito; Reiko Tanaka; Shiho Arishima; Toshio Matsuzaki; Satoshi Ishihara; Takashi Tokashiki; Yusuke Ohya; Hiroshi Takashima; Fujio Umehara; Shuji Izumo; Yuetsu Tanaka
Journal:  Retrovirology       Date:  2013-05-07       Impact factor: 4.602

Review 5.  Cell surface markers in HTLV-1 pathogenesis.

Authors:  Andrea K Kress; Ralph Grassmann; Bernhard Fleckenstein
Journal:  Viruses       Date:  2011-08-16       Impact factor: 5.048

6.  Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.

Authors:  Priya Kannian; Patrick L Green
Journal:  Viruses       Date:  2010-09-24       Impact factor: 5.818

Review 7.  Human T-cell lymphotropic virus: a model of NF-κB-associated tumorigenesis.

Authors:  Zhaoxia Qu; Gutian Xiao
Journal:  Viruses       Date:  2011-06       Impact factor: 5.048

8.  MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes.

Authors:  Klemens Pichler; Grit Schneider; Ralph Grassmann
Journal:  Retrovirology       Date:  2008-11-12       Impact factor: 4.602

Review 9.  Distinct functions of HTLV-1 Tax1 from HTLV-2 Tax2 contribute key roles to viral pathogenesis.

Authors:  Masaya Higuchi; Masahiro Fujii
Journal:  Retrovirology       Date:  2009-12-17       Impact factor: 4.602

10.  Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis.

Authors:  Linda Zane; Junichiro Yasunaga; Yu Mitagami; Venkat Yedavalli; Sai-Wen Tang; Chia-Yen Chen; Lee Ratner; Xiongbin Lu; Kuan-Teh Jeang
Journal:  Retrovirology       Date:  2012-12-21       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.